DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years.
Robert MurrayJennifer BryantPhil TitcombeSheila J BartonHazel InskipNicholas C HarveyCyrus CooperKaren LillycropMark HansonKeith M GodfreyPublished in: Clinical epigenetics (2016)
Our findings suggest developmental epigenetic regulation of ANRIL promoter methylation as a factor in later CHD risk in children.